Granules Stock Screener | Share Price & Fundamental Analysis
GRANULES
Pharmaceuticals
Screen Granules share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹612.20
▲
6.95 (1.15%)
Share Price BSE
₹611.95
▲
6.85 (1.13%)
Market Cap
₹15,135.25 Cr.
P/E Ratio (TTM)
28.96
P/B Ratio
3.73
EPS (TTM)
₹20.69
Dividend Yield
0.24%
Debt to Equity
0.40
52W High
₹619.20
52W Low
₹431.10
Operating Margin
21.00%
Profit Margin
12.36%
Revenue (TTM)
₹1,230.00
EBITDA
₹284.00
Net Income
₹152.00
Total Assets
₹6,253.00
Total Equity
₹3,716.00
Granules Share Price History - Stock Screener Chart
Screen GRANULES historical share price movements with interactive charts. Analyze price trends and patterns.
Granules Company Profile - Fundamental Screener
Screen Granules company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GRANULES shares.
Granules India Limited is a vertically integrated pharmaceutical company founded in 1991. It manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The company specializes in off-patent drugs and first-line defense products like Paracetamol, Ibuprofen, Metformin, and Guaifenesin. Granules India operates seven manufacturing facilities, six in...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
C Krishna Prasad
ISIN
INE101D01020
Website
https://www.granulesindia.com
Granules Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen GRANULES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 6,253 | 5,521 | 4,905 | 4,513 | 3,714 | 3,228 | 2,983 | 2,677 | 1,879 | 1,563 |
| Current Assets | 3,116 | 2,905 | 2,574 | 2,505 | 1,997 | 1,629 | 1,282 | 1,187 | 828 | 818 |
| Fixed Assets | 2,427 | 2,096 | 1,911 | 1,541 | 1,332 | 1,204 | 944 | 777 | 644 | 560 |
| Liabilities | ||||||||||
| Total Liabilities | 6,253 | 5,521 | 4,905 | 4,513 | 3,714 | 3,228 | 2,983 | 2,677 | 1,879 | 1,563 |
| Current Liabilities | 534 | 213 | 256 | 284 | 367 | 491 | 557 | 495 | 188 | 247 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 3,716 | 3,226 | 2,835 | 2,587 | 2,173 | 1,844 | 1,530 | 1,304 | 904 | 662 |
| Share Capital | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 23 | 22 |
| Reserves & Surplus | 3,691 | 3,201 | 2,811 | 2,562 | 2,149 | 1,818 | 1,504 | 1,279 | 881 | 613 |
Screen GRANULES income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,230 | 1,225 | 1,294 | 1,171 | 1,171 | 960 | 1,139 | 1,199 | 984 | 1,190 | 1,150 | 1,034 | 1,024 | 1,156 | 1,147 |
| Expenses | 945 | 989 | 1,019 | 920 | 921 | 763 | 907 | 967 | 849 | 977 | 905 | 837 | 808 | 908 | 915 |
| EBITDA | 284 | 236 | 275 | 251 | 251 | 197 | 232 | 232 | 135 | 213 | 245 | 197 | 216 | 248 | 232 |
| Operating Profit % | 21.00% | 18.00% | 21.00% | 21.00% | 21.00% | 20.00% | 20.00% | 19.00% | 14.00% | 18.00% | 21.00% | 19.00% | 21.00% | 21.00% | 20.00% |
| Depreciation | 64 | 69 | 72 | 53 | 53 | 53 | 57 | 49 | 49 | 53 | 52 | 40 | 43 | 44 | 48 |
| Interest | 24 | 24 | 29 | 29 | 27 | 26 | 27 | 19 | 23 | 26 | 29 | 6 | 7 | 13 | 17 |
| Profit Before Tax | 198 | 145 | 176 | 176 | 181 | 128 | 153 | 164 | 66 | 136 | 170 | 150 | 166 | 190 | 167 |
| Tax | 46 | 32 | 45 | 46 | 47 | 31 | 35 | 44 | 18 | 34 | 45 | 39 | 38 | 45 | 43 |
| Net Profit | 152 | 113 | 131 | 130 | 135 | 97 | 118 | 120 | 48 | 102 | 126 | 111 | 128 | 145 | 124 |
| EPS | 6.27 | 4.64 | 5.38 | 5.35 | 5.56 | 4.01 | 4.85 | 4.94 | 1.98 | 4.22 | 5.18 | 4.48 | 5.14 | 5.85 | 5.11 |
Granules Cash Flow Screener - Liquidity Fundamentals
Screen GRANULES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 867 | 439 | 739 | 332 | 433 | 476 | 262 | -1 | 188 | 151 |
| Investing Activities | -689 | -358 | -192 | -379 | -277 | -160 | -270 | -462 | -326 | -162 |
| Financing Activities | -93 | 8 | -440 | 190 | -299 | -213 | -17 | 529 | 56 | 86 |
| Net Cash Flow | 85 | 90 | 107 | 143 | -144 | 103 | -25 | 66 | -82 | 75 |
Screen GRANULES shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 38.84% | 38.82% | 38.82% | 41.96% | 38.87% | 38.87% | 38.85% | 42.02% |
| FII Holding | 15.15% | 0.00% | 14.09% | 19.57% | 20.39% | 19.49% | 15.87% | 0.00% |
| DII Holding | 22.45% | 22.74% | 17.92% | 10.70% | 14.12% | 14.86% | 19.57% | 5.03% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.07% | 16.54% | 18.28% | 19.38% | 18.78% | 18.29% | 17.45% | 21.13% |
| Other Holding | 7.50% | 21.89% | 10.89% | 8.39% | 7.84% | 8.49% | 8.27% | 31.82% |
| Shareholder Count | 169,802 | 169,700 | 165,542 | 182,142 | 179,870 | 202,198 | 177,554 | 190,894 |
Granules Dividend Screener - Share Yield Analysis
Screen GRANULES dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.50 | 0.25% |
| 2024-March | ₹1.50 | 0.31% |
| 2023-March | ₹1.50 | 0.35% |
| 2022-March | ₹1.50 | 0.52% |
| 2021-March | ₹1.50 | 0.49% |
| 2020-March | ₹1.00 | 0.33% |
| 2019-March | ₹1.00 | 0.70% |
| 2018-March | ₹1.00 | 0.87% |
| 2017-March | ₹0.90 | 0.87% |
Granules Index Membership - Market Screener Classification
Screen GRANULES by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Granules Market Events Screener - Corporate Actions
Screen GRANULES market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-01-22 | 2026-01-22 | Extraordinary General Meeting | NA | 1.84% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -5.09% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -5.95% |
| 2025-08-07 | 2025-08-07 | Annual General Meeting | NA | -16.93% |
| 2025-07-31 | 2025-07-31 | Dividend | ₹ 1.50 /share | -6.98% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 18.10% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | -2.83% |
| 2024-11-06 | 2024-11-06 | Quarterly Result Announcement | NA | -9.57% |
| 2024-08-06 | 2024-08-06 | Annual General Meeting | NA | 60.49% |
| 2024-07-30 | 2024-07-30 | Dividend | ₹ 1.50 /share | 41.19% |
| 2023-08-03 | 2023-08-03 | Dividend | ₹ 1.50 /share | 8.32% |
| 2022-08-22 | Buyback | 400 | -11.32% | |
| 2022-07-19 | 2022-07-21 | Dividend | ₹ 0.75 /share | 22.87% |
| 2022-02-17 | 2022-02-18 | Dividend | ₹ 0.25 /share | -2.02% |
| 2021-11-24 | 2021-11-25 | Dividend | ₹ 0.25 /share | -1.40% |
Granules Competitors Screener - Peer Comparison
Screen GRANULES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,130 | 40.28 | 54,729 | 9.71% | 10,980 | 53.13 |
| Divis Laboratories | 177,439 | 70.98 | 9,712 | 18.67% | 2,191 | 63.15 |
| Torrent Pharmaceuticals | 135,808 | 62.26 | 11,539 | 6.99% | 1,911 | 71.28 |
| Cipla | 120,350 | 22.75 | 28,410 | 7.12% | 5,291 | 57.84 |
| Dr Reddys Laboratories | 105,013 | 18.27 | 33,741 | 16.73% | 5,725 | 46.16 |
| Lupin | 101,140 | 22.61 | 22,910 | 13.74% | 3,306 | 63.46 |
| Zydus Life Science | 94,123 | 18.63 | 23,511 | 18.55% | 4,615 | 54.52 |
| Mankind Pharma | 93,294 | 52.17 | 12,744 | 20.90% | 2,007 | 56.13 |
| Aurobindo Pharma | 73,030 | 20.91 | 32,346 | 9.43% | 3,484 | 60.21 |
| Alkem Laboratories | 68,875 | 28.04 | 13,458 | 3.70% | 2,216 | 55.49 |
Granules Company Announcements - News Screener
Screen GRANULES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Notice Of The Extraordinary General Meeting | View |
| 2026-01-01 | Closure of Trading Window | View |
| 2025-12-29 | Board Meeting Outcome for Outcome Of Board Meeting Dated December 23 2025 | View |
| 2025-12-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-19 | Update | View |
| 2025-12-18 | Board Meeting Intimation for Considering And Evaluating The Proposals For Raising Funds On A Private Placement Basis By Way Of Preferential Issue Including The Determination Of Issue Price Subject To Such Regulatory/Statutory Approvals As May Be Required. | View |
| 2025-12-12 | Updates | View |
| 2025-12-12 | Updates | View |
| 2025-12-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-12-01 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-27 | Updates | View |
| 2025-11-19 | Transcript Of The Earnings Conference Call For Q2 And The Half-Year Of FY26. | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2025-11-13 | Financial Results For The Quarter & Half Year Ended On September 302025 | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |